Kim, Sang Jin
Sonmez, Kemal
Swan, Ryan
Campbell, J. Peter
Ostmo, Susan
Chan, R. V. Paul
Nagiel, Aaron
Drenser, Kimberly A.
Berrocal, Audina M.
Horowitz, Jason D.
Li, Xiaohui
Chen, Yii-Der Ida
Taylor, Kent D.
Simmons, Charles
Rotter, Jerome I.
Chiang, Michael F.
Chiang, Michael F.
Ostmo, Susan
Kim, Sang Jin
Sonmez, Kemal
Campbell, J. Peter
Chan, R. V. Paul
Jonas, Karyn
Horowitz, Jason
Coki, Osode
Eccles, Cheryl-Ann
Sarna, Leora
Orlin, Anton
Berrocal, Audina
Negron, Catherin
Denser, Kimberly
Cumming, Kristi
Osentoski, Tammy
Check, Tammy
Zajechowski, Mary
Lee, Thomas
Kruger, Evan
McGovern, Kathryn
Simmons, Charles
Murthy, Raghu
Galvis, Sharon
Rotter, Jerome
Chen, Ida
Li, Xiaohui
Taylor, Kent
Roll, Kaye
Kalpathy-Cramer, Jayashree
Erdogmus, Deniz
Ioannidis, Stratis
Martinez-Castellanos, Maria Ana
Salinas-Longoria, Samantha
Romero, Rafael
Arriola, Andrea
Olguin-Manriquez, Francisco
Meraz-Gutierrez, Miroslava
Dulanto-Reinoso, Carlos M.
Montero-Mendoza, Cristina
,
Funding for this research was provided by:
National Institutes of Health (R01EY19474, P30EY10572)
National Institute of Diabetes and Digestive and Kidney Diseases (DK063491)
National Center for Advancing Translational Sciences (UL1TR001881)
Article History
Received: 14 February 2020
Accepted: 1 February 2021
First Online: 2 March 2021
Competing interests
: Michael Chiang is an unpaid member of the Scientific Advisory Board for Clarity Medical Systems (Pleasanton, CA), a Consultant for Novartis (Basel, Switzerland), and an initial member of Inteleretina. R. V. Paul Chan is a Consultant for Visunex Medical Systems (Fremont, CA) and a Consultant for Alcon (Fort Worth, TX), Allergan (Irvine, CA), and Bausch and Lomb (St. Louis, MO). Rest of the authors declare to have no competing interest.